Lexington, MA, United States of America

Cameron Stuver Moody

This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cameron Stuver Moody. Retrieved from https://idiyas.com/inventor/cameron-stuver-moody

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cameron Stuver Moody: Innovator in CAK Inhibition

Introduction

Cameron Stuver Moody is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit cyclin-dependent kinase-activating kinase (CAK). His work is crucial for advancing treatments for various diseases.

Latest Patents

Cameron holds a patent for "CAK inhibitors and uses thereof." This invention relates to compounds that serve as inhibitors of CAK, along with compositions that utilize these compounds. The methods described in the patent are aimed at treating CAK-mediated diseases, including fungal infections. He has 1 patent to his name.

Career Highlights

Cameron is currently employed at Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His role at Vertex allows him to work on cutting-edge research that has the potential to impact patient care significantly.

Collaborations

Cameron has collaborated with notable colleagues, including Brian Ledford and Michael D Mullican. These partnerships enhance the research environment and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Cameron Stuver Moody is a notable inventor whose work in CAK inhibition represents a significant advancement in the treatment of diseases. His contributions to Vertex Pharmaceuticals, Inc. and the field of biotechnology underscore his commitment to innovation and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…